KATHLEEN K SCHOEMAKER
CIK 1207789 · last filed 2015-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$315.74M
Companies
21
Total Filings
58
Lifetime Open-Market Net
$110.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GKOS | 10%+ Owner | 876,083 | $126.81 | $111.10M | $0 | 1 | 2015-07-01 |
| LIFE | 10%+ Owner | 13,414 | $15.61 | $209.4K | $0 | 1 | 2015-05-12 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | 10%+ Owner | 2,057,142 | $0.55 | $1.13M | $20.15M | 1 | 2014-08-07 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 33,890 | — | — | $0 | 1 | 2014-03-17 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | 10%+ Owner | 13,004 | $38.22 | $497.0K | $0 | 1 | 2014-02-04 |
| TNDM | 10%+ Owner | 3,189,058 | $16.60 | $52.94M | $0 | 1 | 2013-11-19 |
| VCYT | 10%+ Owner | 3,063,294 | $47.33 | $144.99M | $0 | 1 | 2013-11-04 |
| Evoke Pharma Inc (OMED) Delisted | 10%+ Owner | 5,250 | — | — | $0 | 1 | 2013-09-30 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | 10%+ Owner | 4,614 | — | — | $3.00M | 1 | 2013-08-28 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | 10%+ Owner | 1,897,336 | — | — | $8.00M | 1 | 2013-07-16 |
| ESPR | 10%+ Owner | 2,066,935 | $3.15 | $6.51M | $4.00M | 1 | 2013-07-02 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 79,422 | $0.08 | $6.4K | $10.86M | 2 | 2013-06-05 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | 10%+ Owner | 88,011 | — | — | $13.44M | 6 | 2013-03-21 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 159,896 | — | — | $0 | 3 | 2013-01-18 |
| Durata Therapeutics, Inc. (DRTX) Delisted | 10%+ Owner | 22,306 | — | — | $7.06M | 1 | 2012-07-24 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | 10%+ Owner | 59,701 | — | — | $25.33M | 15 | 2011-12-22 |
| ZOGENIX, INC. (ZGNX) Delisted | 10%+ Owner | 169,251 | $26.68 | $4.52M | $16.40M | 2 | 2011-09-20 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 18,864 | $5.54 | $104.5K | $4.10M | 2 | 2011-06-03 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | 10%+ Owner | 3,115,960 | — | — | -$514.6K | 3 | 2009-01-30 |
| Volcano Corp (VOLC) Delisted | 10%+ Owner | 1,898,427 | — | — | -$985.0K | 8 | 2008-07-18 |
| SENORX INC (SENO) Delisted | 10%+ Owner | 24,665 | — | — | $0 | 1 | 2007-04-03 |
Recent Filings · Page 6 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-06-14 | Volcano Corp (VOLC) Delisted | Other (J) | +19,135 | $0 | EDGAR |
| 2007-06-06 | Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Sell (S) | −24,500 | -$275.9K | EDGAR |
| 2007-06-05 | Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Other (J) | −834,300 | $0 | EDGAR |
| 2007-05-29 | Volcano Corp (VOLC) Delisted | Other (J) | +17,273 | $0 | EDGAR |
| 2007-05-22 | Volcano Corp (VOLC) Delisted | Sell (S) | −25,247 | -$486.0K | EDGAR |
| 2007-05-11 | Volcano Corp (VOLC) Delisted | Other (J) | −1,204,815 | $0 | EDGAR |
| 2007-05-01 | Orexigen Therapeutics, Inc. (OREX) Delisted | Mixed | +4,288,807 | $6.30M | EDGAR |
| 2007-04-03 | SENORX INC (SENO) Delisted | Conv (C) | +1,369,448 | $0 | EDGAR |
Showing 51–58 of 58
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.